(Q38152275)

29 August 2017

title

Personalized medicine in neurodegenerative diseases: how far away? (English)

1 reference

29 August 2017

1 reference

personalized medicine

1 reference

4

1 reference

29 August 2017

Kristina Gotovac

1

1 reference

29 August 2017

Sanja Hajnšek

series ordinal

2

1 reference

29 August 2017

Marija Bošnjak Pašić

series ordinal

3

1 reference

29 August 2017

Fran Borovečki

series ordinal

5

1 reference

29 August 2017

publication date

1 February 2014

1 reference

Molecular Diagnosis and Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

18

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

17-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s40291-013-0058-z

29 August 2017

exact match

0 references

cites work

An integrated encyclopedia of DNA elements in the human genome

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

How can we realize the promise of personalized antidepressant medicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Alzheimer mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

The acetylation of tau inhibits its function and promotes pathological tau aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

The genetics of Alzheimer disease: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Unraveling the biological mechanisms in Alzheimer's disease--lessons from genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Imaging as a strategy for premortem diagnosis and staging of tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Neural stem cell-based treatment for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Genetics of Parkinson disease and other movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Biomarkers in Parkinson's disease (recent update).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Deep brain stimulation: current and future clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Genes associated with multiple sclerosis: 15 and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Genomics in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Personalized medicine in multiple sclerosis: hope or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Prediction of long-term disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

The long-range interaction landscape of gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Neuroscience in the era of functional genomics and systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Synthetic biology and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Development of novel genomic blood biomarkers for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0058-Z

Translational and systems medicine

21 January 2018

1 reference

12 December 2020

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

1 reference

12 December 2020

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis

1 reference

12 December 2020

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

12 December 2020

MicroRNAs in Parkinson's disease

1 reference

12 December 2020

Deep brain stimulation, brain maps and personalized medicine: lessons from the human genome project

1 reference

12 December 2020

Personalized clinical laboratory diagnostics

1 reference

12 December 2020

Plasma-based circulating MicroRNA biomarkers for Parkinson's disease

1 reference

12 December 2020

Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.

1 reference

12 December 2020

10.1007/S40291-013-0058-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1001881367

0 references

1 reference